CONNECTICUT MYOPIA CENTER
Our CONNECTICUT MYOPIA CENTER is dedicated to myopia control and treatment.
We provide the latest technology with FDA approved treatment, as well as other novel treatment including Orthokeratology, MiSight and Multifocal lenses. and therapeutic eyedrops
What Is Myopia and The Complication Of Uncontrolled Myopia?
Myopia, also known as nearsightedness, is an eye condition causing inability to see distance clearly.
Myopia affects 42% of American population, and still grows in prevalence globally.
It is the most common cause of impaired vision in people under the age of 40 and affects daily activities of living.
Majority of myopia occurs in the school age children where the eyes continue to grow,
and can be rapidly worsening with age and seriously affects children’s school, sports and other daily activities.
Uncontrolled myopia can progress to high myopia or degenerative myopia,
and significantly increases the risk of serious vision-threatening diseases
such as retinal and macular degenerations, retinal breaks, retinal detachment, cataract, and glaucoma
that can cause loss of vision. Treating myopia and controlling progression is essential
to prevent the development of sight threatening eye diseases.
How Does Myopia Develop?
Myopia develops when the eyeball is excessively elongated from front to back
(or when the cornea is overly curved that causes a mismatch in focusing power of the cornea and the length of eyeball), light images of objects cannot be focused properly on the retina (a light-detecting neural tissue
lying in the back of the eye), making distant vision blurry but near vision unaffected.
The exact cause of myopia remains unknown.
The shape and length of the eyeball, genetic and environmental factors,
reduced outdoor activities, and excessive near visual tasks, particularly increased digital screen times,
are all contributing to myopia development
How Is Myopia Treated?
Myopia is commonly treated with prescription glasses and traditional contact lenses,
which help refocusing lights correctly onto the retina to make vision clear.
However, most often, a stronger prescription is needed yearly to adequately correct vision.
Refractive eye laser surgeries such as LASIK, Epi-LASIK, PRK and SMILE
are the treatment options for the right candidates in adult myopic patients.
Other options for certain very high myopic adult patients are Refractive Lens Exchange
where the natural crystal lens is surgically replaced with an artificial intraocular lens,
as well as Phakic Intraocular Lenses surgery
where a small thin intraocular lens of right power is implanted permanently
inside the eye in front of the natural lens to help reduce the needs for glasses or contact lenses.
Our Connecticut Myopia Center provides the latest technology for Myopic treatment
with new FDA approved and other novel treatment beyond traditional corrective lens
We use Orthokeratology, Multifocal and MiSight Contact lenses, and off-label use of therapeutic eyedrops.
We have been certified to prescribe FDA approved Paragon CRT Ortho-K lenses
for non-surgical Corneal Refractive Therapy of myopia since early 2018.
We have also been certified to prescribe FDA approved MiSight lenses
for myopia control and treatment in children since early 2022.
Please call our offices at
203-626-5155 (Wallingford Office) and 203-504-9370 (Cheshire Office)
to schedule your appointment to evaluate appropriate treatment options
for you or your child
Our CONNECTICUT MYOPIA CENTER is dedicated to myopia control and treatment.
We provide the latest technology with FDA approved treatment, as well as other novel treatment including Orthokeratology, MiSight and Multifocal lenses. and therapeutic eyedrops
What Is Myopia and The Complication Of Uncontrolled Myopia?
Myopia, also known as nearsightedness, is an eye condition causing inability to see distance clearly.
Myopia affects 42% of American population, and still grows in prevalence globally.
It is the most common cause of impaired vision in people under the age of 40 and affects daily activities of living.
Majority of myopia occurs in the school age children where the eyes continue to grow,
and can be rapidly worsening with age and seriously affects children’s school, sports and other daily activities.
Uncontrolled myopia can progress to high myopia or degenerative myopia,
and significantly increases the risk of serious vision-threatening diseases
such as retinal and macular degenerations, retinal breaks, retinal detachment, cataract, and glaucoma
that can cause loss of vision. Treating myopia and controlling progression is essential
to prevent the development of sight threatening eye diseases.
How Does Myopia Develop?
Myopia develops when the eyeball is excessively elongated from front to back
(or when the cornea is overly curved that causes a mismatch in focusing power of the cornea and the length of eyeball), light images of objects cannot be focused properly on the retina (a light-detecting neural tissue
lying in the back of the eye), making distant vision blurry but near vision unaffected.
The exact cause of myopia remains unknown.
The shape and length of the eyeball, genetic and environmental factors,
reduced outdoor activities, and excessive near visual tasks, particularly increased digital screen times,
are all contributing to myopia development
How Is Myopia Treated?
Myopia is commonly treated with prescription glasses and traditional contact lenses,
which help refocusing lights correctly onto the retina to make vision clear.
However, most often, a stronger prescription is needed yearly to adequately correct vision.
Refractive eye laser surgeries such as LASIK, Epi-LASIK, PRK and SMILE
are the treatment options for the right candidates in adult myopic patients.
Other options for certain very high myopic adult patients are Refractive Lens Exchange
where the natural crystal lens is surgically replaced with an artificial intraocular lens,
as well as Phakic Intraocular Lenses surgery
where a small thin intraocular lens of right power is implanted permanently
inside the eye in front of the natural lens to help reduce the needs for glasses or contact lenses.
Our Connecticut Myopia Center provides the latest technology for Myopic treatment
with new FDA approved and other novel treatment beyond traditional corrective lens
We use Orthokeratology, Multifocal and MiSight Contact lenses, and off-label use of therapeutic eyedrops.
We have been certified to prescribe FDA approved Paragon CRT Ortho-K lenses
for non-surgical Corneal Refractive Therapy of myopia since early 2018.
We have also been certified to prescribe FDA approved MiSight lenses
for myopia control and treatment in children since early 2022.
Please call our offices at
203-626-5155 (Wallingford Office) and 203-504-9370 (Cheshire Office)
to schedule your appointment to evaluate appropriate treatment options
for you or your child